Emmaus Life Sciences, Inc. (EMMA) Reports Q2 Loss of $0.02

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $2.82 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• Jefferies Financial Group (JEF) Tops Q3 EPS by 8c
• EigenQ and Silicon Valley Acquisition file S-4 for merger
• Pathfinder Bancorp (PBHC) Declares $0.10 Quarterly Dividend; 2.3% Yield